Tam, Lai-Shan
Chinese University of Hong Kong · Prince of Wales Hospital
2 papers on CoChatORCID 0000-0001-6410-8852
Most cited papers
- Verified
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
Baeten, D., Østergaard, M., Wei, J. C.-C., Sieper, J., Järvinen, P., Tam, L.-S., Salvarani, C., Kim, T.-H., Solinger, A., Datsenko, Y., et al. (2018) · Annals of the Rheumatic Diseases
Spondyloarthritis Studies and TreatmentsPsoriasis: Treatment and Pathogenesis
Cited by 390
- Verified
Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis
Tam, L.-S., Tomlinson, B., Chu, T. T., Li, T. K., & Li, E. K. (2007) · Clinical Rheumatology
Rheumatoid Arthritis Research and TherapiesAdipokines, Inflammation, and Metabolic Diseases
Cited by 197
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free